embrace for research
Decentralize your trials with digital endpoints and a powerful end-to-end platform
Using industry-leading wearable devices, collect data remotely with instant access through an intuitive online portal. Conducting trials at scale from patients’ homes has never been easier.
Get started
A complete platform for decentralized, virtual, and hybrid clinical trials
Embrace for Research is a fully integrated platform for conducting real-world trials across multiple sites. Empatica’s powerful Embrace2 and EmbracePlus wearables can continuously and accurately record and send physiological information to the cloud, enabling virtually unlimited data and scalability. And through the Research Portal, researchers can cost-effectively conduct multi-site studies and analyze data remotely and securely, accelerating their findings and reducing costs.
Multi-site studies
Build a research team and check the progress of multiple sites at a glance
Team management
Each study or site created is isolated, you can fine-tune access levels for each team member
Easy set-up
By deploying a one-time-use QR code scan, we simplify subject enrollment while ensuring that there are no ID errors
Optimal research platform
Review deployed device status and monitor subject compliance in real time
Our products are trusted by the world’s most renowned pharmaceutical companies, hospitals and academics
DIGITAL ENDPOINT VALIDATION STUDY
VeraSci
VeraSci’s Innovation Lab has been conducting an NIH-funded study examining the relationship between real-time measurements of gait and actigraphy, collected by the Embrace2, and established cognitive and functional endpoints that are sensitive to decline early in the Alzheimer’s disease continuum. Their preliminary data suggest a positive correlation between in-clinic measurements and the endpoints developed using Embrace2 data for monitoring the patient's cognitive health.
Download the case study
DRUG EFFICIENCY TRIAL
Sunovion Pharmaceuticals
Sunovion Pharmaceuticals utilized the Embrace for Research platform during their international multi-site phase-4 anti-epileptic drug trial. Empatica’s FDA-cleared seizure detection algorithm and the Mate app e-diary allowed them to continuously monitor patients, gaining an objective insight into patients’ seizure counts while remotely monitoring subject compliance throughout the study.
FLU PREVENTION STUDY
Biomedical Advanced Research and Development Authority
The US government’s Biomedical Advanced Research and Development Authority (BARDA) is working to develop a digital endpoint for detecting the earliest signs of the flu. Through the use of Embrace2 wearables and Empatica data analysis expertise, they engaged in a prospective study monitoring healthy individuals throughout the flu season with the aim to develop an early detection system.
MENTAL HEALTH STUDY
Harvard University
Harvard University Clinical Psychologist Dr. Matthew K. Nock is using Embrace for Research to detect digital phenotypes related to suicidal thoughts in a multi-site study involving hundreds of individuals wearing Embrace2. This is the largest-yet study about suicidal behavior also measuring skin conductance levels as an objective way to assess changes in physiological distress in the participants.
BIOFEEDBACK
4YouandMe
4YouandMe, a non-profit company founded by Dr. Stephen H. Friend has partnered with clinicians at Oxford University and Mount Sinai School of Medicine to conduct a multi-site prospective cohort study, utilizing the Embrace to monitor signs of stress and symptoms of Crohn's disease. The aim of this project is to provide biofeedback to patients with Crohn’s, in order to potentially prevent negative clinical changes in their condition.
ZERO GRAVITY STUDY
MIT Media Lab
MIT Media Lab’s doctoral student, Kristina T. Johnson has embarked on a journey to measure autonomic changes in parabolic flyers. Parabolic flight planes are notorious for inducing high levels of nausea. By using Empatica’s technology and other biosignal measures, Kristy and her team were able to gain an objective insight to novice and veteran flyers’ physiological well-being during flights.
How does Embrace for Research work?
Embrace2
Embrace2's sensors measure physiological parameters including electrodermal activity, motion, and skin temperature, which are continuously sent via Bluetooth® to the Mate App
Mate
The Mate App automatically transfers the received Embrace data and diary entries to Empatica's cloud. A subset of the processed data are visualized in the app's 24-hours wheel
Research Portal
Through the Research Portal you can manage your studies and access raw and processed data received from the subjects
fda-cleared
embrace2
Continuous and accurate participant data
A medical-grade wearable to continuously measure physiological parameters, giving insights into sleep, activity, autonomic arousal, and seizures for many different typologies of clinical/research studies.
Patented technology
Collect objective biometric data
Clinical-grade sensors
EDA, PPG, Accelerometer and Gyroscope
Non-stop data collection
Thanks to sophisticated sensors, on-board memory and continuous data streaming
Continuous monitoring of the Sympathetic Nervous System
The only smartwatches to offer continuous EDA data streaming
Award-winning design
Maximum comfort and wearability, to improve subject recruitment, retention, and compliance
Technical specifications
EDA Sensor
- Sampling frequency: 4Hz (fixed)
- Resolution: 55 fSiemens
- Range: 0 μSiemens - 80μ - 80 e:
- AC excitation, 4Hz, max.
- Electrodes (applied parts):
- Placement on either the ventral (inner) wrist or dorsal (outer) wrist.
Temperature Sensor
- Sampling frequency: 1Hz
- Range: -20ºC to 70ºC
- Resolution: 0.15ºC
3-Axis accelerometer
- Sampling frequency: 32Hz
- High sensitivity motion detection on 3 axes:
- Range ± 16g.
- Resolution: 16 bits
Gyroscope
- Sampling frequency: 32Hz
- High sensitivity motion detection on 3 axes
- Range ± 500 degrees/sec.
- Resolution: 16 bits
Every Empatica device at a glance
Unsure which Empatica device better suits your research needs? Receive a handy comparison chart directly to your inbox, and review all sensors, specs, and biomarkers from our devices at any time
By submitting your email you are consenting to receive communications about Empatica's products and servicesMate App
An end to paper diaries
The Mate App keeps participants engaged while it collects, visualizes, and transmits device data to the Research Portal, where you can review it at a glance.
- Safeguard participant engagement through a simple, user-friendly app.
- Complement device data with self-reporting from participants, via daily e-diary entries, that can provide insights for understanding subjective outcomes.
- Encourages patients to stay engaged throughout your study by visualizing their sleep and activity data.
- Secure and reliable data transfer and visualization. A unique identifier also ensures that the subject’s data is partitioned correctly and stored securely.
hiipa compliant
Research Portal
Easily manage and access data from multiple sites and studies
The Research Portal allows research teams, CRO personnel, and study coordinators to visualize, monitor, and download data from different types of longitudinal and clinical studies on the cloud.
Take a look
Maintain full control
Manage investigations, check compliance, manage multiple sites, and collect data from different types of research studies, all within one platform
Build your own team
Create a flawlessly organized hierarchy and easily delegate tasks (e.g. enrollment, data collection) with the Research Portal
Go global
Easy management of sites, studies, and teams, enabling global teamwork and easy remote subject enrollment and management
Easily customizable
Customize the platform according to your research needs (such as type of research, type of data or events that need to be collected)
Gain full visibility raw data
Instantly access and download raw data from all devices
Discover how Embrace2 for Research can empower your study
Potential savings per patient
Using Electronic Data Capture (EDC) can result in significant savings throughout all the phases of clinical trials. This graph illustrates an estimation of how much a pharmaceutical company can save per patient in each phase if using a solution like Embrace2 for Research.
Phase I
Phase II
Phase III
Phase I
Total saving per patient
(Phase I)
Total saving per patient
(Phase I and II)
Total saving per patient
(Phase I, II and III)
Support at every step of the way
The Empatica promise:
- All our clients benefit from detailed and dedicated onboarding, including an account manager and site support to walk you through every step of the process
- We handle the logistics and provide IRB materials so you can focus on your research
- Dedicated customer and technical support
- Start collecting data in less than 5 minutes with auto-generated QR codes for participant enrollment
Meeting global safety and security standards
What is your multi-site research goal?
Talk with our experts to discover how Embrace for Research can empower your investigation.
Talk to our team
